Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
novartis
6
×
biotech
gene therapy
national top stories
national
boston blog main
boston top stories
cancer
clinical trials
deals
fda
genentech
new york top stories
roche
san francisco top stories
zolgensma
biogen
car-t
crispr
europe blog main
europe top stories
hemophilia
indiana blog main
indiana top stories
medicaid
new york blog main
pfizer
san francisco blog main
spark therapeutics
spinal muscular atrophy
achromatopsia
acquisitions
acute lymphoblastic leukemia
administration
advanced therapies
alzheimer's
amgen
atmp
What
therapy
6
×
gene
fda
drug
new
patients
access
address
advanced
age
approval
approved
approves
atrophy
becker
bigger
biggest
billions
bio
blueprint
cancer
capacity
car
carries
cell
certain
chemistry
cmc
come
consistent
consolidation
controls
crispr
daily
deal
designed
dollars
eaton
emerging
ensure
Language
unset
Current search:
therapy
×
novartis
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy